Drug Iatrogenesis: A Review

Abstract

The Drug iatrogenesis corresponds to the pathology or any clinical manifestation undesirable for the patient induced by the administration of one or more medicines. Several studies have estimated that adverse drug reactions account for between 0.5% and 2% of outpatient consultations and are involved in 4% to 10% of hospital admissions Thus, we will present definitions essential to the understanding of drug-induced iatrogenesis before synthesizing the different epidemiological data available in this field.

Current Understanding of Toxins and Toxicity Associated With Novel Detection Methods

“…Several studies estimate that drug related adverse reactions account for about 0.5% to 2% of the outpatient consultations and are responsible for 4% to 10% of all hospital admissions. Moutaouakkil et al [1], have reviewed this phenomenon of drug iatrogenesis and provided the epidemiological data available in this field.…”

“…The current issue of Toxicology: Open Access presents some exciting reports on varied topics such as: drug iatrogenesis, toxicity of Iron oxide nanoparticles (FeNPs), mycotoxins, and jelly fish toxins. Moutaouakkil et al [1], have authored a review on drug iatrogenesis. Zhang et al [2], investigated the nanotoxicity of dimercaptosuccinic acid (DMSA) coated iron oxide nanoparticles.…”